COVID-19 may worsen radiation lung damage in breast cancer patients, study suggests

NCT ID NCT07188116

First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 24 times

Summary

This study will look back at medical records of 200 breast cancer patients to see if those who had COVID-19 are more likely to develop lung inflammation (pneumonitis) from radiation therapy. Researchers will compare the rate, severity, and timing of this side effect between patients with and without a history of COVID-19. The goal is to better understand risks and improve care for breast cancer patients undergoing radiation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhejiang Hospital, Department of Oncology, Hangzhou, China, 310030

    Hangzhou, Zhejiang, 310030, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.